Platinum Investment Management LTD Vertex Pharmaceuticals Inc Transaction History

Platinum Investment Management LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$234.96 - $292.55 $85,290 - $106,195	-363 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$221.42 - $260.97 $12,178 - $14,353	-55 Reduced 13.16%	363 $95,000
Q4 2021 Feb 11, 2022	SELL	$177.01 - $223.45 $9,381 - $11,842	-53 Reduced 11.25%	418 $92,000
Q3 2021 Nov 09, 2021	SELL	$181.39 - $202.99 $13,967 - $15,630	-77 Reduced 14.05%	471 $85,000
Q2 2021 Aug 11, 2021	BUY	$187.49 - $221.1 $18,749 - $22,110	100 Added 22.32%	548 $110,000

Q1 2021 May 13, 2021	BUY	$207.02 - $241.31 $92,744 - $108,106	448 New	448 $96,000

1,623

222M

1.35M

1.49M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $120B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on Platinum Investment Management LTD with notifications on news.